Notice of Ordering Period Extension-Clinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Place of performance: United Kingdom
Free. Verify your email, then we send one reminder only.
- Posted
- Jul 16, 2026
- Closes
- Rolling, no fixed deadline
Similar opportunities open now
- Procurement of Office Furniture and Secure Storage Units for Workspace Optimization and Regulatory ComplianceSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Contract for Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental NeurotoxicitySame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Acquisition of a High-Sensitivity Preclinical Quantitative microSPECT Imaging SystemSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Development of White Matter Atlases for the Baltimore Longitudinal Study of AgingOpenU.S. General Services Administration (SAM.gov)No deadline listed
- 6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge Amendment 0001OpenVETERANS AFFAIRS, DEPARTMENT OFCloses in 30 days
At a glance
This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the all other professional, scientific, and technical services category. Applications are accepted on a rolling basis. Work is performed in United Kingdom.
Classification and identifiers
- Industry (NAICS)
- All Other Professional, Scientific, and Technical Services (541990)
- Product or service (PSC)
- Chemical/Biological Studies and Analysis (B504)
- Solicitation number
- 75N95024D00002
- Contracting office
- NATIONAL INSTITUTES OF HEALTH NIDA
Who can apply
About this opportunity
INTRODUCTION PURSUANT TO RFO SUBPART 5.101- PRESOLICITATION NOTICE, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION. THIS IS A NOTICE OF INTENT TO AWARD A MODIFICATION UNDER CONTRACT NO. 75N95024D00002 WITH THE UNIVERSITY OF EXETER, UNITED KINGDOM, TO EXTEND THE ORDERING PERIOD BY ONE (1) YEAR. The National Institute on Aging (NIA) intends to modify the single-award Indefinite Quantity Indefinite Delivery (IDIQ) contract no. 75N95024D00002, Clinical evaluation of Phenserine tartrate Extended Controlled Release Tablet (ECRT) formulation in early mild Alzheimer’s disease and mild to moderate traumatic brain injury. This modification will extend the ordering period as denoted in IDIQ contract clause FAR 52.216-18, Ordering (AUG 2020), to be extended from August 1, 2026, to August 1, 2027. The ...